ArticleAdvances in therapy2026

Comparative Effectiveness of Mepolizumab Versus Dupilumab in Medicare Fee-for-Service Beneficiaries with Asthma: A Real-World Cohort Study.

Guillaume Germain et al.PubMed ↗Publisher ↗

No numbers read from the abstract.